Insmed Incorporated
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Insmed Incorporated 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About INSM
Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline.
CEOWilliam H. Lewis
CEOWilliam H. Lewis
Employees1,271
Employees1,271
HeadquartersBridgewater, New Jersey
HeadquartersBridgewater, New Jersey
Founded1988
Founded1988
Employees1,271
Employees1,271
INSM Key Statistics
Market cap19.35B
Market cap19.35B
Price-Earnings ratio-17.13
Price-Earnings ratio-17.13
Dividend yield—
Dividend yield—
Average volume2.90M
Average volume2.90M
High today$102.41
High today$102.41
Low today$97.34
Low today$97.34
Open price$98.11
Open price$98.11
Volume3.16M
Volume3.16M
52 Week high$106.83
52 Week high$106.83
52 Week low$60.40
52 Week low$60.40
Analyst ratings
100%
of 19 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own INSM. This list is generated using Robinhood data, and it’s not a recommendation.